The advertisement promotes Stivarga® (regorafenib) as a treatment option for previously treated metastatic colorectal cancer (mCRC), highlighting its safety information and the importance of monitoring liver function during treatment.
Creative Information
| CID: | 8811e2cc-adea-46a4-9642-7c30e90d0754 |
| CRID: | 82_1075-793366 |
| Domain: | stivarga-us.com |
| Seat: | PP |
| Size: | 160x600 |
| Bid: | $4.00 |
| Timestamp: | 10/31/2025, 6:37:23 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 7:52:33 PM | 7.12s | |
| adomain_analysis | success | 10/31/2025, 9:19:33 PM | 3.21s | |
| adomain_capture | success | 10/31/2025, 9:19:30 PM | 0.08s | |
| ad_render | success | 10/31/2025, 7:52:26 PM | 25.02s | |
| brand_mapping | success | 10/31/2025, 6:37:24 PM | 1.10s | |
Analysis Results
Ad Format: banner
Brands: Stivarga
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 963.82 KB | ||||||||||||||||||||||
| Render Time: | 9.35 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 969.42 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Landing Page
Creatives
